A Flash-Induced Robust Cu Electrode on Glass Substrates and Its Application for Thin-Film μLEDs
Black-Box Optimization for Automated Discovery
ConspectusIn chemistry and supplies science, researchers and engineers uncover, design, and optimize chemical compounds or supplies with their skilled information and strategies. At the very best stage of abstraction, this course of is formulated as black-box optimization. For occasion, the trial-and-error course of of synthesizing numerous molecules for higher materials properties could be thought to be optimizing a black-box perform describing the relation between a chemical system and its properties.
Various black-box optimization algorithms have been developed within the machine studying and statistics communities. Recently, plenty of researchers have reported profitable functions of such algorithms to chemistry. They embrace the design of photofunctional molecules and medical medicine, optimization of thermal emission supplies and excessive Li-ion conductive strong electrolytes, and discovery of a brand new part in inorganic skinny movies for photo voltaic cells.
There are all kinds of algorithms accessible for black-box optimization, comparable to Bayesian optimization, reinforcement studying, and lively studying. Practitioners want to pick an acceptable algorithm or, in some circumstances, develop novel algorithms to fulfill their calls for. It can also be vital to find out tips on how to finest mix machine studying strategies with quantum mechanics- and molecular mechanics-based simulations, and experiments. In this Account, we give an summary of latest research relating to automated discovery, design, and optimization based mostly on black-box optimization.
The Account covers the next algorithms: Bayesian optimization to optimize the chemical or bodily properties, an optimization methodology utilizing a quantum annealer, best-arm identification, gray-box optimization, and reinforcement studying. In addition, we introduce lively studying and boundless objective-free exploration, which can not fall into the class of black-box optimization.Data high quality and amount are key for the success of those automated discovery strategies. As laboratory automation and robotics are put ahead, automated discovery algorithms would be capable of match human efficiency at the least in some domains within the close to future.

The Emergence of RNA from the Heterogeneous Products of Prebiotic Nucleotide Synthesis
Recent advances in prebiotic chemistry are starting to stipulate believable pathways for the synthesis of the canonical ribonucleotides and their meeting into oligoribonucleotides. However, these response pathways counsel that many noncanonical nucleotides are more likely to have been generated alongside the usual ribonucleotides. Thus, the oligomerization of prebiotically synthesized nucleotides is more likely to have led to a extremely heterogeneous assortment of oligonucleotides comprised of a variety of forms of nucleotides linked by a wide range of spine linkages.
Recombinant Human CCL4 |
|||
| MBS258300-0005mg | MyBiosource | 0.005mg | EUR 305 |
Recombinant Human CCL4 |
|||
| MBS258300-5x0005mg | MyBiosource | 5x0.005mg | EUR 1210 |
Recombinant Human CCL4 |
|||
| MBS7609419-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Human CCL4 |
|||
| MBS7609419-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Human CCL4 |
|||
| MBS7609419-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human CCL4 |
|||
| MBS7609419-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
Recombinant Human CCL4 |
|||
| Z100685 | ABM | 10 µg | EUR 85 |
|
Description: Macrophage Inflammatory Protein-1 is a factor produced by macrophages that causes local inflammatory responses, and induces superoxide production by neutrophils. Two peptides are responsible for this activity. They have been termed MIP-1-alpha, and MIP-1-beta. The two MIP proteins are the major factors produced by macrophages following their stimulation with bacterial endotoxins. Both proteins are involved in the cell activation of human granulocytes (neutrophils, eosinophils, and basophils) and appear to be involved in acute neutrophilic inflammation. Both forms of MIP-1 stimulate the production of reactive oxygen species in neutrophils and the release of lysosomal enzymes. They also induce the synthesis of other pro-inflammatory cytokines such as IL-1, IL-6 and TNF in fibroblasts and macrophages. MIP-1-alpha is a potent agonist of basophils, inducing a rapid change of cytosolic free calcium (see also: Calcium ionophore), the release of histamine and sulfido- leukotrienes, and Chemotaxis. Murine MIP-1- alpha is the primary stimulator of TNF secretion by macrophages, whereas MIP-1-beta antagonizes the inductive effects of MIP-1- alpha. In human monocytes the production of MIP-1-beta can be induced by bacterial lipopolysaccharides and IL-7. The biological activities of MIP-1-alpha and MIP-1-beta are mediated by receptors that bind both factors CCR5. A second species of receptors for these two factors also appears to bind MCAF. |
|||
Recombinant Human CCL4 |
|||
| Z100687 | ABM | 100 µg | EUR 390 |
|
Description: Macrophage Inflammatory Protein-1 is a factor produced by macrophages that causes local inflammatory responses, and induces superoxide production by neutrophils. Two peptides are responsible for this activity. They have been termed MIP-1-alpha, and MIP-1-beta. The two MIP proteins are the major factors produced by macrophages following their stimulation with bacterial endotoxins. Both proteins are involved in the cell activation of human granulocytes (neutrophils, eosinophils, and basophils) and appear to be involved in acute neutrophilic inflammation. Both forms of MIP-1 stimulate the production of reactive oxygen species in neutrophils and the release of lysosomal enzymes. They also induce the synthesis of other pro-inflammatory cytokines such as IL-1, IL-6 and TNF in fibroblasts and macrophages. MIP-1-alpha is a potent agonist of basophils, inducing a rapid change of cytosolic free calcium (see also: Calcium ionophore), the release of histamine and sulfido- leukotrienes, and Chemotaxis. Murine MIP-1- alpha is the primary stimulator of TNF secretion by macrophages, whereas MIP-1-beta antagonizes the inductive effects of MIP-1- alpha. In human monocytes the production of MIP-1-beta can be induced by bacterial lipopolysaccharides and IL-7. The biological activities of MIP-1-alpha and MIP-1-beta are mediated by receptors that bind both factors CCR5. A second species of receptors for these two factors also appears to bind MCAF. |
|||
Recombinant Human CCL4 |
|||
| Z100689 | ABM | 1.0 mg | EUR 2025 |
|
Description: Macrophage Inflammatory Protein-1 is a factor produced by macrophages that causes local inflammatory responses, and induces superoxide production by neutrophils. Two peptides are responsible for this activity. They have been termed MIP-1-alpha, and MIP-1-beta. The two MIP proteins are the major factors produced by macrophages following their stimulation with bacterial endotoxins. Both proteins are involved in the cell activation of human granulocytes (neutrophils, eosinophils, and basophils) and appear to be involved in acute neutrophilic inflammation. Both forms of MIP-1 stimulate the production of reactive oxygen species in neutrophils and the release of lysosomal enzymes. They also induce the synthesis of other pro-inflammatory cytokines such as IL-1, IL-6 and TNF in fibroblasts and macrophages. MIP-1-alpha is a potent agonist of basophils, inducing a rapid change of cytosolic free calcium (see also: Calcium ionophore), the release of histamine and sulfido- leukotrienes, and Chemotaxis. Murine MIP-1- alpha is the primary stimulator of TNF secretion by macrophages, whereas MIP-1-beta antagonizes the inductive effects of MIP-1- alpha. In human monocytes the production of MIP-1-beta can be induced by bacterial lipopolysaccharides and IL-7. The biological activities of MIP-1-alpha and MIP-1-beta are mediated by receptors that bind both factors CCR5. A second species of receptors for these two factors also appears to bind MCAF. |
|||
Recombinant Human CCL4 |
|||
| 50191P | Leinco Technologies | 1 Each | Ask for price |
Recombinant Human CCL4 |
|||
| 50191P-100 | Leinco Technologies | 1 Each | Ask for price |
Recombinant Human CCL4 |
|||
| 50191P-1000 | Leinco Technologies | 1 Each | Ask for price |
Recombinant Human CCL4 |
|||
| 50191P-20 | Leinco Technologies | 1 Each | Ask for price |
Recombinant Human CCL4 |
|||
| 50191P-5 | Leinco Technologies | 1 Each | Ask for price |
Recombinant Human CCL4 |
|||
| 50191P-50 | Leinco Technologies | 1 Each | Ask for price |
Recombinant Human CCL4 |
|||
| 50191P-1 | QED Bioscience | 100 µg | Ask for price |
|
Description: Recombinant human CCL4 |
|||
Recombinant Human CCL4 |
|||
| 50191P-100-1 | QED Bioscience | 100 µg | Ask for price |
|
Description: Recombinant human CCL4 |
|||
Recombinant Human CCL4 |
|||
| 50191P-1000-1 | QED Bioscience | 1000 µg | Ask for price |
|
Description: Recombinant human CCL4 |
|||
Recombinant Human CCL4 |
|||
| 50191P-20-1 | QED Bioscience | 20 µg | Ask for price |
|
Description: Recombinant human CCL4 |
|||
Recombinant Human CCL4 |
|||
| 50191P-5-1 | QED Bioscience | 5 µg | Ask for price |
|
Description: Recombinant human CCL4 |
|||
Recombinant Human CCL4 |
|||
| 50191P-50-1 | QED Bioscience | 50 µg | Ask for price |
|
Description: Recombinant human CCL4 |
|||
Recombinant Human CCL4 protein |
|||
| MBS1562327-005mg | MyBiosource | 0.05mg | EUR 320 |
Recombinant Human CCL4 protein |
|||
| MBS1562327-01mg | MyBiosource | 0.1mg | EUR 410 |
Recombinant Human CCL4 protein |
|||
| MBS1562327-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Human CCL4 Recombinant Protein |
|||
| R00703-3 | BosterBio | 5ug/vial | EUR 350 |
|
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Human CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
|||
Recombinant Human CCL4, biotinylated |
|||
| 50191PB | Leinco Technologies | 1 Each | Ask for price |
Recombinant Human CCL4, biotinylated |
|||
| 50191PB-10 | Leinco Technologies | 1 Each | Ask for price |
Recombinant Human CCL4, biotinylated |
|||
| 50191PB-100 | Leinco Technologies | 1 Each | Ask for price |
Recombinant Human CCL4, biotinylated |
|||
| 50191PB-2 | Leinco Technologies | 1 Each | Ask for price |
Recombinant Human CCL4, biotinylated |
|||
| 50191PB-50 | Leinco Technologies | 1 Each | Ask for price |
Recombinant Human CCL4, biotinylated |
|||
| 50191PB-1 | QED Bioscience | 10 µg | Ask for price |
|
Description: Recombinant human CCL4 |
|||
Recombinant Human CCL4, biotinylated |
|||
| 50191PB-10-1 | QED Bioscience | 10 µg | Ask for price |
|
Description: Recombinant human CCL4 |
|||
Recombinant Human CCL4, biotinylated |
|||
| 50191PB-100-1 | QED Bioscience | 100 µg | Ask for price |
|
Description: Recombinant human CCL4 |
|||
Recombinant Human CCL4, biotinylated |
|||
| 50191PB-2-1 | QED Bioscience | 2 µg | Ask for price |
|
Description: Recombinant human CCL4 |
|||
Recombinant Human CCL4, biotinylated |
|||
| 50191PB-50-1 | QED Bioscience | 50 µg | Ask for price |
|
Description: Recombinant human CCL4 |
|||
Recombinant Human CCL4, GST-tagged |
|||
| CCL4-10850H | Creative BioMart | 25ug | EUR 255.2 |
|
Description: The protein is stored in PBS buffer at -20℃. Avoid repeated freezing and thawing cycles. |
|||
Recombinant Human MIP-1β/CCL4 |
|||
| P6587-100μg | Beyotime Biotech Inc | 100 µg | Ask for price |
Recombinant Human MIP-1β/CCL4 |
|||
| P6587-10μg | Beyotime Biotech Inc | 10 µg | Ask for price |
Recombinant Human MIP-1β/CCL4 |
|||
| P6587-500μg | Beyotime Biotech Inc | 500 µg | Ask for price |
Recombinant Human CCL4/MIP-1β Protein |
|||
| RP01654 | Abclonal | 20μg | EUR 116.9 |
Recombinant Human MIP-1 beta/CCL4 |
|||
| HECCP-0401 | Cyagen | 10ug | Ask for price |
Human MIP-1 beta (CCL4) Recombinant |
|||
| MBS553044-0002mg | MyBiosource | 0.002mg | EUR 165 |
Human MIP-1 beta (CCL4) Recombinant |
|||
| MBS553044-001mg | MyBiosource | 0.01mg | EUR 245 |
RecombinantMIP-1β/CCL4,Human |
|||
| BK0137 | Bioworld Biotech | 1mg | EUR 2200 |
|
Description: The EC50 value of human MIP-1 beta /CCL4 on Caˆ2+ mobilization assay in CHO-K1/ Gα15/hCCR5 cells (human Gα15 and human CCR5 stably expressed in CHO-K1 cells) is less than 100 ng/ml. |
|||
RecombinantMIP-1β/CCL4,Human |
|||
| BK0271 | Bioworld Biotech | 1mg | EUR 3360 |
|
Description: The EC50 value of human MIP-1 beta /CCL4 on Caˆ2+ mobilization assay in CHO-K1/ Gα15/hCCR5 cells (human Gα15 and human CCR5 stably expressed in CHO-K1 cells) is less than 150 ng/ml. |
|||
CCL4 Protein, Human, Recombinant (His Tag) |
|||
| E45H51004Y2-20-ug | EnoGene | 20 ug | EUR 480.73 |
CCL4 Protein, Human, Recombinant (His Tag) |
|||
| MBS8120561-002mg | MyBiosource | 0.02mg | EUR 275 |
CCL4 Protein, Human, Recombinant (His Tag) |
|||
| MBS8120561-01mg | MyBiosource | 0.1mg | EUR 510 |
CCL4 Protein, Human, Recombinant (His Tag) |
|||
| MBS8120561-1mg | MyBiosource | 1mg | EUR 2795 |
CCL4 Protein, Human, Recombinant (His Tag) |
|||
| MBS8120561-5x1mg | MyBiosource | 5x1mg | EUR 12430 |
CCL4 Protein, Human, Recombinant (His Tag) |
|||
| PH51004Y2 | Leading Biology |
|
|
Recombinant Human CCL4 protein (N-His)(active) |
|||
| MBS2569901-002mg | MyBiosource | 0.02mg | EUR 270 |
Recombinant Human CCL4 protein (N-His)(active) |
|||
| MBS2569901-01mg | MyBiosource | 0.1mg | EUR 690 |
Recombinant Human CCL4 protein (N-His)(active) |
|||
| MBS2569901-5x01mg | MyBiosource | 5x0.1mg | EUR 3105 |
Recombinant Human CCL4 protein(N-His)(active) |
|||
| PKSH034170-100ug | Elabscience Biotech | 100ug | EUR 739 |
|
Description: Human |
|||
Recombinant Human CCL4 protein(N-His)(active) |
|||
| PKSH034170-20ug | Elabscience Biotech | 20ug | EUR 249 |
|
Description: Human |
|||
Recombinant Human MIP-1 Beta/CCL4 protein |
|||
| CD01281-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | EUR 409 |
|
Description: CCL4 encoded by the CCL4 gene, also known as Macrophage Inflammatory Protein-1β (MIP-1β) is a CC chemokine with specificity for CCR5 receptors and it is a major HIV-suppressive factor produced by CD8+ T cells. It is a monokine with inflammatory and chemokinetic properties. Recombinant CCL4 induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). Specifically, MIP-1-beta (3-69) is also a ligand for CCR1 and CCR2 isoform B. Recombinant human CCL4 contains 69 amino acids and it shares 77 % and 80 % a.a. sequence identity with Mouse and rat CCL4, respectively. Both human and Mouse MIP-1α and MIP-1β are active on human and Mouse hematopoietic cells. |
|||
Recombinant Human MIP-1 Beta/CCL4 protein |
|||
| CD01281-2ug | Jiaxing Korain Biotech Ltd (BT Labs) | 2ug | EUR 176 |
|
Description: CCL4 encoded by the CCL4 gene, also known as Macrophage Inflammatory Protein-1β (MIP-1β) is a CC chemokine with specificity for CCR5 receptors and it is a major HIV-suppressive factor produced by CD8+ T cells. It is a monokine with inflammatory and chemokinetic properties. Recombinant CCL4 induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). Specifically, MIP-1-beta (3-69) is also a ligand for CCR1 and CCR2 isoform B. Recombinant human CCL4 contains 69 amino acids and it shares 77 % and 80 % a.a. sequence identity with Mouse and rat CCL4, respectively. Both human and Mouse MIP-1α and MIP-1β are active on human and Mouse hematopoietic cells. |
|||
Recombinant Human MIP-1 Beta (CCL4) Protein |
|||
| PROTQ8NHW4-2 | BosterBio | 10ug | EUR 380.4 |
|
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant human MIP-1βis a 7.6 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
|||
Human CCL4 Recombinant Protein Fc Tag Lyophilized |
|||
| IHUCCL4RFCLY10UG | Innovative research | each | EUR 438 |
|
Description: Human CCL4 Recombinant Protein Fc Tag Lyophilized |
|||
Human CCL4 Recombinant Protein Fc Tag Lyophilized |
|||
| IHUCCL4RFCLY50UG | Innovative research | each | EUR 592 |
|
Description: Human CCL4 Recombinant Protein Fc Tag Lyophilized |
|||
Human CCL4 Recombinant Protein Fc Tag Lyophilized |
|||
| MBS8431474-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Human CCL4 Recombinant Protein Fc Tag Lyophilized |
|||
| MBS8431475-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Human C-C motif chemokine 4 (CCL4) |
|||
| MBS949051-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 995 |
Recombinant Human C-C motif chemokine 4 (CCL4) |
|||
| MBS949051-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 560 |
Recombinant Human C-C motif chemokine 4 (CCL4) |
|||
| MBS949051-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Human C-C motif chemokine 4 (CCL4) |
|||
| MBS949051-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 665 |
Recombinant Human C-C motif chemokine 4 (CCL4) |
|||
| MBS949051-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 875 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-5ug |
|||
| QP10227-ec-5ug | EnQuireBio | 5ug | EUR 184.8 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-2ug |
|||
| QP10228-ec-2ug | EnQuireBio | 2ug | EUR 184.8 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-1mg |
|||
| QP5256-1mg | EnQuireBio | 1mg | EUR 3427.2 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-20ug |
|||
| QP10227-ec-20ug | EnQuireBio | 20ug | EUR 348 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-10ug |
|||
| QP10228-ec-10ug | EnQuireBio | 10ug | EUR 348 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-100ug |
|||
| QP10227-ec-100ug | EnQuireBio | 100ug | EUR 1185.6 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-250ug |
|||
| QP10227-ec-250ug | EnQuireBio | 250ug | EUR 2077.2 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-500ug |
|||
| QP5256-500ug | EnQuireBio | 500ug | EUR 2133.6 |
Recombinant Rat CCL4 |
|||
| 6567 | Immunochemistry | 5 µg | EUR 194 |
Recombinant Rat CCL4 |
|||
| MBS258297-0005mg | MyBiosource | 0.005mg | EUR 305 |
Recombinant Rat CCL4 |
|||
| MBS258297-5x0005mg | MyBiosource | 5x0.005mg | EUR 1210 |
Recombinant Rat CCL4 |
|||
| MBS7609984-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Rat CCL4 |
|||
| MBS7609984-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Rat CCL4 |
|||
| MBS7609984-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Rat CCL4 |
|||
| MBS7609984-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
Recombinant Rat CCL4 |
|||
| RECCP-0401 | Cyagen | 5ug | Ask for price |
Recombinant Mouse CCL4 |
|||
| 6568 | Immunochemistry | 5 µg | EUR 194 |
Recombinant Mouse CCL4 |
|||
| MBS258298-0005mg | MyBiosource | 0.005mg | EUR 305 |
Recombinant Mouse CCL4 |
|||
| MBS258298-5x0005mg | MyBiosource | 5x0.005mg | EUR 1210 |
Recombinant Mouse CCL4 |
|||
| MBS7609439-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Mouse CCL4 |
|||
| MBS7609439-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Mouse CCL4 |
|||
| MBS7609439-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Mouse CCL4 |
|||
| MBS7609439-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
Recombinant Mouse CCL4 |
|||
| MBS7610645-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Mouse CCL4 |
|||
| MBS7610645-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Mouse CCL4 |
|||
| MBS7610645-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Mouse CCL4 |
|||
| MBS7610645-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
Recombinant Murine CCL4 |
|||
| MECCP-0401 | Cyagen | 10ug | Ask for price |
CCL4 Recombinant Protein |
|||
| 90-380 | ProSci | 10 ug | EUR 405.6 |
|
Description: CCL4, (C-C motif chemokine 4; macrophage inflammatory protein 1beta) is a chemokine secreted at sites of inflammation by activated leukocytes, lymphocytes, vascular endothelial cells and pulmonary smooth cells. CCL4 attracts a variety of immune cells to sites of microbial infection as well as to pathologic inflammation, such as allergic asthma and ischemic myocardium. Full-length and truncated CCL4 exert biological activity through the receptor CCR5. The truncated form of CCL4 interacts additionally with CCR1 and CCR2b. The ability of CCL4 to bind CCR5 inhibits the cellular entry of M-tropic HIV. Both CCL4 forms block HIV-1 infection of T cells by inducing the downregulation of CCR5. |
|||
CCL4 Recombinant Protein |
|||
| 90-381 | ProSci | 50 ug | EUR 519 |
|
Description: CCL4, (C-C motif chemokine 4; macrophage inflammatory protein 1beta) is a chemokine secreted at sites of inflammation by activated leukocytes, lymphocytes, vascular endothelial cells and pulmonary smooth cells. CCL4 attracts a variety of immune cells to sites of microbial infection as well as to pathologic inflammation, such as allergic asthma and ischemic myocardium. Full-length and truncated CCL4 exert biological activity through the receptor CCR5. The truncated form of CCL4 interacts additionally with CCR1 and CCR2b. The ability of CCL4 to bind CCR5 inhibits the cellular entry of M-tropic HIV. Both CCL4 forms block HIV-1 infection of T cells by inducing the downregulation of CCR5. |
|||
Recombinant Human C-C motif chemokine 4 protein (CCL4) |
|||
| MBS9422922-0005mg | MyBiosource | 0.005mg | EUR 210 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) |
|||
| MBS9422922-002mg | MyBiosource | 0.02mg | EUR 365 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) |
|||
| MBS9422922-01mg | MyBiosource | 0.1mg | EUR 1135 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) |
|||
| MBS9422922-025mg | MyBiosource | 0.25mg | EUR 1990 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) |
|||
| MBS9422922-05mg | MyBiosource | 0.5mg | EUR 2570 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) |
|||
| MBS9422923-001mg | MyBiosource | 0.01mg | EUR 365 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) |
|||
| MBS9422923-01mg | MyBiosource | 0.1mg | EUR 1135 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) |
|||
| MBS9422923-025mg | MyBiosource | 0.25mg | EUR 1990 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) |
|||
| MBS9422923-05mg | MyBiosource | 0.5mg | EUR 2570 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) |
|||
| MBS9422923-1mg | MyBiosource | 1mg | EUR 3465 |
Recombinant Human Macrophage Inflammatory protein-1 beta (CCL4) |
|||
| 7-02020 | CHI Scientific | 2µg | Ask for price |
Recombinant Human Macrophage Inflammatory protein-1 beta (CCL4) |
|||
| 7-02021 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Macrophage Inflammatory protein-1 beta (CCL4) |
|||
| 7-02022 | CHI Scientific | 1mg | Ask for price |
Recombinant Human Macrophage Inflammatory Protein-1 beta/CCL4 |
|||
| AP60299 | SAB | 100ug | EUR 896 |
Recombinant Human Macrophage Inflammatory protein-1 beta (CCL4) |
|||
| MBS142014-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Human Macrophage Inflammatory protein-1 beta (CCL4) |
|||
| MBS142014-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Human Macrophage Inflammatory protein-1 beta (CCL4) |
|||
| MBS142014-1mg | MyBiosource | 1mg | EUR 2880 |
Recombinant Human Macrophage Inflammatory protein-1 beta (CCL4) |
|||
| MBS142014-5x1mg | MyBiosource | 5x1mg | EUR 12630 |
Recombinant Human Macrophage Inflammatory Protein-1 beta/CCL4 |
|||
| P1459-.01 | ApexBio | 10ug | EUR 272.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human Macrophage Inflammatory Protein-1 beta/CCL4 |
|||
| P1459-.1 | ApexBio | 100ug | EUR 900 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human Macrophage Inflammatory Protein-1 beta/CCL4 |
|||
| P1459-.5 | ApexBio | 500ug | EUR 2021.6 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human MIP-1 beta (rHu MIP-1 beta /CCL4 |
|||
| JOT-PR1095 | Jotbody | 2µg | EUR 205 |
|
Description: Determined by its ability to chemoattract human blood monocytes using a concentration range of 5.0-20.0 ng/ml, corresponding to a Specific Activity of >5 x 104 IU/mg. |
|||
Recombinant Human MIP-1 beta (rHu MIP-1 beta /CCL4 |
|||
| PR1095 | Bioworld Biotech | 2µg | EUR 158 |
|
Description: Determined by its ability to chemoattract human blood monocytes using a concentration range of 5.0-20.0 ng/ml, corresponding to a Specific Activity of >5 x 104 IU/mg. |
|||
Human Macrophage Inflammatory Protein-1 beta (CCL4), (Recombinant) |
|||
| 22060541-1 | Bio-WORLD | 2 µg | EUR 190.94 |
Macrophage Inflammatory Protein-1 Beta Human Recombinant (CCL4) |
|||
| rAP-0225 | Angio Proteomie | Inquiry | Ask for price |
CCL4 Recombinant Rabbit mAb |
|||
| BS48648 | Bioworld Biotech | 50 ul | EUR 398 |
|
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
|||
Macrophage Inflammatory Protein 1 beta (CCL4) (NM_002984) Human Recombinant Protein |
|||
| E45H37254M5 | EnoGene | 20 ug | EUR 785.42 |
Macrophage Inflammatory Protein 1 beta (CCL4) (NM_002984) Human Recombinant Protein |
|||
| PROTP13236 | BosterBio | Regular: 10ug | EUR 1249 |
|
Description: Recombinant protein of human chemokine (C-C motif) ligand 4 (CCL4), transcript variant 1 |
|||
Recombinant CCL4 (MIP-1beta) |
|||
| MBS191498-0005mg | MyBiosource | 0.005mg | EUR 175 |
Recombinant CCL4 (MIP-1beta) |
|||
| MBS191498-002mg | MyBiosource | 0.02mg | EUR 285 |
Recombinant CCL4 (MIP-1beta) |
|||
| MBS191498-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant CCL4 (MIP-1beta) |
|||
| MBS191498-01mg | MyBiosource | 0.1mg | EUR 605 |
Recombinant CCL4 (MIP-1beta) |
|||
| MBS191498-1mg | MyBiosource | 1mg | EUR 2540 |
Rat CCL4 Recombinant Protein |
|||
| R00703-6 | BosterBio | 5ug/vial | EUR 350 |
|
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Rat CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
|||
Recombinant Human C-C motif chemokine 4 protein(CCL4) (Active) |
|||
| AP73309 | SAB | 1mg | EUR 3939 |
Recombinant Human C-C motif chemokine 4 protein(CCL4) (Active) |
|||
| AP73310 | SAB | 1mg | EUR 3939 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
| CSB-AP000861HU | Cusabio | 8352 mg | Ask for price |
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
| CSB-AP000861HU-100ug | Cusabio | 100ug | Ask for price |
|
Description: 24-92aa |
|||
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
| CSB-AP000861HU-10ug | Cusabio | 10ug | Ask for price |
|
Description: 24-92aa |
|||
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
| CSB-AP000861HU-500ug | Cusabio | 500ug | Ask for price |
|
Description: 24-92aa |
|||
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
| MBS969203-0005mg | MyBiosource | 0.005mg | EUR 210 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
| MBS969203-01mg | MyBiosource | 0.1mg | EUR 970 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
| MBS969203-05mg | MyBiosource | 0.5mg | EUR 2045 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
| MBS969203-5x05mg | MyBiosource | 5x0.5mg | EUR 8935 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
| MBS969204-001mg | MyBiosource | 0.01mg | EUR 355 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
| MBS969204-01mg | MyBiosource | 0.1mg | EUR 970 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
| MBS969204-05mg | MyBiosource | 0.5mg | EUR 2045 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
| MBS969204-5x05mg | MyBiosource | 5x0.5mg | EUR 8935 |
Mouse CCL4 Recombinant Protein |
|||
| R00703-4 | BosterBio | 5ug/vial | EUR 350 |
|
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Mouse CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
|||
Swine CCL4 Recombinant Protein |
|||
| R00703-7 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Swine CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
|||
Bovine CCL4 Recombinant Protein |
|||
| R00703 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Bovine CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
|||
Canine CCL4 Recombinant Protein |
|||
| R00703-1 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Canine CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
|||
Rabbit CCL4 Recombinant Protein |
|||
| R00703-5 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Rabbit CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
|||
Chicken CCL4 Recombinant Protein |
|||
| R00703-2 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Chicken CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
|||
Porcine Chemokine CCL4 Recombinant |
|||
| IPCCCL4R25UG | Innovative research | each | EUR 482 |
|
Description: Porcine Chemokine CCL4 Recombinant |
|||
Porcine Chemokine CCL4 Recombinant |
|||
| IPCCCL4R5UG | Innovative research | each | EUR 283 |
|
Description: Porcine Chemokine CCL4 Recombinant |
|||
Porcine Chemokine CCL4 Recombinant |
|||
| MBS8420997-0005mg | MyBiosource | 0.005mg | EUR 435 |
Porcine Chemokine CCL4 Recombinant |
|||
| MBS8420997-0025mg | MyBiosource | 0.025mg | EUR 595 |
Porcine Chemokine CCL4 Recombinant |
|||
| MBS8420997-5x0025mg | MyBiosource | 5x0.025mg | EUR 2450 |
Recombinant (E.Coli) Human Macrophage Inflammatory protein-1 beta (CCL4) |
|||
| RP-1009 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Macrophage Inflammatory Protein-1 Beta Human Recombinant (CCL4) (MIP 1b Human) |
|||
| PT_41532 | Novatein Biosciences, Inc. |
|
|
Macrophage Inflammatory Protein 1 beta, Recombinant, Human (MIP-1b, CCL4) |
|||
| MBS650449-0002mg | MyBiosource | 0.002mg | EUR 340 |
Macrophage Inflammatory Protein 1 beta, Recombinant, Human (MIP-1b, CCL4) |
|||
| MBS650449-001mg | MyBiosource | 0.01mg | EUR 490 |
Macrophage Inflammatory Protein 1 beta, Recombinant, Human (MIP-1b, CCL4) |
|||
| MBS650449-5x001mg | MyBiosource | 5x0.01mg | EUR 2055 |
Macrophage Inflammatory Protein 1 beta, Recombinant, Human (MIP-1b, CCL4) |
|||
| MBS650572-0002mg | MyBiosource | 0.002mg | EUR 340 |
Macrophage Inflammatory Protein 1 beta, Recombinant, Human (MIP-1b, CCL4) |
|||
| MBS650572-001mg | MyBiosource | 0.01mg | EUR 490 |
Macrophage Inflammatory Protein 1 beta, Recombinant, Human (MIP-1b, CCL4) |
|||
| MBS650572-5x001mg | MyBiosource | 5x0.01mg | EUR 2055 |
We evaluation the results on copying the kinetics of nucleotides with altered nucleobase and sugar moieties, when they’re current as activated monomers and when they’re included into primer and template oligonucleotides. We additionally talk about three variations in spine connectivity, all of that are nonheritable and regenerate native RNA upon being copied. The kinetic superiority of RNA synthesis means that nonenzymatic copying served as a chemical choice mechanism that allowed comparatively homogeneous RNA to emerge from a posh combination of prebiotically synthesized nucleotides and oligonucleotides.